Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 0093-8310

5 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 0093-8310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Image 1
Chemical structure of Eletriptan Hydrobromide, showing its molecular components and bonds representative of this active pharmaceutical ingredient.*
FDA Label Image

Image 2

Image 2
A line graph showing the estimated probability of response over time from initial dose in hours for Eletriptan Hydrobromide tablets at 20 mg, 40 mg, and 80 mg doses compared to double-blind placebo. The x-axis represents time in hours (0 to 2), and the y-axis shows the estimated probability of response (0.0 to 0.9). Various dashed lines correspond to different dose levels.*
FDA Label Image

Image 3

Image 3
A line graph depicting the probability of a second dose or other medication over time in hours following an initial dose. The graph compares multiple groups: double blind placebo, eletriptan 20 mg, eletriptan 40 mg, and eletriptan 80 mg, each represented by distinct symbols in the legend. The y-axis represents the probability from 0 to 0.9, and the x-axis represents time from 0 to 24 hours.*
FDA Label Image

Image 4

Image 4
Eletriptan Hydrobromide Tablets 20 mg film-coated oral tablets packaging label by Teva Pharmaceuticals USA, Inc. The carton shows the dosage strength, quantity of 1 card x 6 tablets, storage instructions, barcode, and manufacturing information indicating production in Canada by Teva Canada Limited. The label highlights prescription-only status and child-resistant packaging.*
FDA Label Image

Image 5

Image 5
Packaging label for Eletriptan Hydrobromide Tablets 40 mg, film coated oral tablets by Teva Pharmaceuticals USA, Inc. The label shows the NDC 0093-8311-18 and indicates a package size of 1 card containing 6 tablets. The label includes storage instructions and manufacturer information for Teva Canada Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.